As scientists and clinicians race to develop effective treatments to improve survival from COVID-19 and a vaccine to control the SARS-CoV-2 virus, Health Affairs has launched a new project to help identify for policy makers the critical decisions they will face that will have a substantial effect on whether and how quickly society reaps the benefits of these advances.

You are invited to join us on Monday, August 24, for a virtual symposium when some of the top minds in the field will join Health Affairs Editor-in-Chief Alan Weil for a discussion of these issues. Segments will focus on "Innovation" and "Equitable Access to Vaccines and Therapeutics."

Featuring:

Margaret A. Hamburg, Former Commissioner, US Food and Drug Administration
Orin Levine, Director, Global Delivery Programs, Bill & Melinda Gates Foundation
Rena M. Conti, Dean’s Research Scholar, Questrom School of Business, Boston University; Associate Professor, Markets, Public Policy, And Law; Associate Research Director, Institute For Health System Innovation And Policy
Mark Feinberg, President and CEO, IAVI
Garth Graham, Vice President and Chief Community Health Officer, CVS Health
Nicole Lurie, Strategic Adviser to the CEO, CEPI; Senior Lecturer, Harvard Medical School; and former Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services
Angela K. Shen, Visiting Research Scientist, Vaccine Education Center, Children’s Hospital of Philadelphia, and Captain (Ret.), US Public Health Services
Rebecca Lynn Weintraub, Assistant Professor of Medicine, Assistant Professor of Global Health and Social Medicine, Harvard Medical School
Gavin Mark Yamey, Professor, Practice of Global Health, Sanford School of Public Policy, Duke University
Others to be announced

Health Affairs is grateful to the following sponsors for their support of this work and this symposium: Anthem, Inc., Amgen Inc., Avalere, Kaiser Permanente, Pharmaceutical Research and Manufacturers of America (PhRMA), Gilead Sciences, McKesson, Quest Diagnostics, Dynavax, Alexion, and Danaher.

TODAY ON THE BLOG

COVID-19

Moving On From Telehealth-By-Desperation: What Will Make Telehealth Stick
By Lori Uscher-Pines

While many providers have found telehealth ideal for improving access to care during the pandemic, telehealth visits are already declining and may continue to decline. Without permanent policy changes, it is unclear if telehealth services will represent a significant proportion of US health care visits in the long run. Read More >>

POLITICS

Democrats Will Adopt Their Health Care Platform Next Week—Here’s What It Says
By Billy Wynne

The platform reiterates some hallmarks of Democratic philosophy while addressing current challenges like the COVID-19 pandemic and adding new details to long-sought policy goals, such as a public option. Read More >>

IN THE JOURNAL

RESEARCH ARTICLE: WOMEN’S HEALTH

Compared With Other Countries, Women In The US Are More Likely Than Men To Forgo Medicines Because Of Cost
By Jamie R. Daw and Michael R. Law

Nonadherence to prescription medicines because of cost is associated with adverse clinical outcomes. Jamie Daw and Michael Law find that in eleven high-income countries, the largest disparities in nonadherence for women compared with men occur in the US, Canada, and Australia, which are among the countries in which out-of-pocket spending for pharmaceuticals is the highest. Read More >>

About Health Affairs

Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here. I